These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9914257)

  • 41. Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase.
    Dessauer CW; Chen-Goodspeed M; Chen J
    J Biol Chem; 2002 Aug; 277(32):28823-9. PubMed ID: 12058044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase.
    Ramos-Espiritu L; Kleinboelting S; Navarrete FA; Alvau A; Visconti PE; Valsecchi F; Starkov A; Manfredi G; Buck H; Adura C; Zippin JH; van den Heuvel J; Glickman JF; Steegborn C; Levin LR; Buck J
    Nat Chem Biol; 2016 Oct; 12(10):838-44. PubMed ID: 27547922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The class III adenylyl cyclases: multi-purpose signalling modules.
    Linder JU; Schultz JE
    Cell Signal; 2003 Dec; 15(12):1081-9. PubMed ID: 14575863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gs alpha meets its target--shedding light on a key signal transduction event.
    Dumas JJ; Lambright DG
    Structure; 1998 Apr; 6(4):407-11. PubMed ID: 9562564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allosteric regulation of nucleotidyl cyclases: an emerging pharmacological target.
    Seifert R; Beste KY
    Sci Signal; 2012 Sep; 5(240):pe37. PubMed ID: 22949734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenylyl cyclase type II domains involved in Gbetagamma stimulation.
    Weitmann S; Schultz G; Kleuss C
    Biochemistry; 2001 Sep; 40(36):10853-8. PubMed ID: 11535062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G protein regulation of adenylate cyclase.
    Simonds WF
    Trends Pharmacol Sci; 1999 Feb; 20(2):66-73. PubMed ID: 10101967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells.
    Anand-Srivastava MB
    Biochemistry; 2000 May; 39(21):6503-13. PubMed ID: 10828966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
    Mou TC; Gille A; Fancy DA; Seifert R; Sprang SR
    J Biol Chem; 2005 Feb; 280(8):7253-61. PubMed ID: 15591060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase.
    Yan SZ; Huang ZH; Andrews RK; Tang WJ
    Mol Pharmacol; 1998 Feb; 53(2):182-7. PubMed ID: 9463474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Truncation and alanine-scanning mutants of type I adenylyl cyclase.
    Tang WJ; Stanzel M; Gilman AG
    Biochemistry; 1995 Nov; 34(44):14563-72. PubMed ID: 7578062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.
    Dessauer CW; Watts VJ; Ostrom RS; Conti M; Dove S; Seifert R
    Pharmacol Rev; 2017 Apr; 69(2):93-139. PubMed ID: 28255005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guanylyl cyclases with the topology of mammalian adenylyl cyclases and an N-terminal P-type ATPase-like domain in Paramecium, Tetrahymena and Plasmodium.
    Linder JU; Engel P; Reimer A; Krüger T; Plattner H; Schultz A; Schultz JE
    EMBO J; 1999 Aug; 18(15):4222-32. PubMed ID: 10428960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
    Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
    Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenylyl and guanylyl cyclase assays.
    Kelly JJ; Stevens T; Thompson WJ; Seifert R
    Curr Protoc Pharmacol; 2005 Oct; Chapter 2():Unit2.2. PubMed ID: 21953389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning of guanylyl cyclase isoforms.
    Nakane M; Murad F
    Adv Pharmacol; 1994; 26():7-18. PubMed ID: 7913620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization and crystallization of a minimal catalytic core domain from mammalian type II adenylyl cyclase.
    Zhang G; Liu Y; Qin J; Vo B; Tang WJ; Ruoho AE; Hurley JH
    Protein Sci; 1997 Apr; 6(4):903-8. PubMed ID: 9098900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Dictyostelium homologue of mammalian soluble adenylyl cyclase encodes a guanylyl cyclase.
    Roelofs J; Meima M; Schaap P; Van Haastert PJ
    EMBO J; 2001 Aug; 20(16):4341-8. PubMed ID: 11500361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.
    Steegborn C; Litvin TN; Hess KC; Capper AB; Taussig R; Buck J; Levin LR; Wu H
    J Biol Chem; 2005 Sep; 280(36):31754-9. PubMed ID: 16002394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme.
    Tews I; Findeisen F; Sinning I; Schultz A; Schultz JE; Linder JU
    Science; 2005 May; 308(5724):1020-3. PubMed ID: 15890882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.